Magnesium L-Threonate

Magnesium L-threonate (branded Magtein) is magnesium bound to L-threonic acid, a metabolite of vitamin C. It was engineered on a specific hypothesis — that it raises magnesium concentrations in the brain better than other salts — and is sold as a cognition / “brain magnesium” nootropic. The rodent work behind that hypothesis is real and the mechanism is coherent, but the human evidence is a handful of small, mostly industry-funded trials with soft or inconsistent endpoints, so the marketing runs well ahead of the data. It is also a low-elemental form (~8% magnesium by weight), which makes it a poor and expensive choice for simply correcting a magnesium shortfall. For magnesium’s established uses and intake references, see Magnesium.

What the Evidence Says

The case for this specific form rests on ~six small human RCTs plus a well-developed rodent literature. None of the applications below clear the bar of independent, adequately powered replication; the two strongest signals (cognition, sleep) come almost entirely from trials funded or supplied by the compound’s commercial developers, and where an objective, pre-specified endpoint was used the effect often disappeared.

Application	Support	Rests on
Cognition & memory	█████░░░░░ 48%	3 small RCTs (n≈44–109), all industry-linked; positive on soft composites but null on Raven’s fluid-intelligence 1,2Reference 1Liu et al. · 2016RCTEfficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults — [RCT, small, industry-funded]View study →Reference 2Lopresti et al. · 2025RCTThe effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults — [RCT, branded; null on Raven’s fluid-intelligence and objective sleep]View study →; one trial confounded by phosphatidylserine + vitamins 4Reference 4Zhang et al. · 2022RCTA Magtein®, magnesium L-threonate-based formula improves brain cognitive functions in healthy Chinese adults — [RCT, confounded: formula also contained phosphatidylserine + vitamins C and D]View study →; strong rodent mechanism 7,8Reference 7Slutsky et al. · 2010AnimalEnhancement of learning and memory by elevating brain magnesium — [animal, rat]View study →Reference 8Li et al. · 2013AnimalElevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in an Alzheimer’s disease mouse model — [animal, mouse]View study →
Sleep quality	████░░░░░░ 38%	2 RCTs: subjective + wearable improvements 3Reference 3Hausenblas et al. · 2024RCTMagnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems — [RCT, industry-linked] (corrigendum 2025, PMID 40567408)View study →, but null on objective sleep in the second and positive only on some subjective items 2Reference 2Lopresti et al. · 2025RCTThe effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults — [RCT, branded; null on Raven’s fluid-intelligence and objective sleep]View study →
Pain / opioid-sparing	███░░░░░░░ 30%	Split: one positive opioid-sparing trial in advanced cancer 5Reference 5Wu et al. · 2023RCTOral application of magnesium-L-threonate enhances analgesia and reduces the dosage of opioids needed in advanced cancer patients — [RCT]View study →, one null for post-mastectomy pain 6Reference 6Ni et al. · 2023RCTA randomized, double-blind, placebo-controlled trial of magnesium-L-threonate for persistent pain after breast cancer surgery — [RCT, null]View study →

Cognition & memory. The anchor trial, MMFS-01 (Liu 2016, n=44, 12 weeks, older adults with cognitive complaints), reported a large improvement on a four-domain cognitive composite (Cohen’s d≈0.91) — but it was single-site, funded by the developer (Neurocentria), and small ^{1Reference 1Liu et al. · 2016RCTEfficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults — [RCT, small, industry-funded]View study →}. A 2025 Magtein trial (Lopresti, n=100, healthy poor-sleepers, 6 weeks, 2 g/day) improved the NIH Cognition composite (p=0.043) and a derived “brain-age” measure, yet found no effect on Raven’s Progressive Matrices (fluid intelligence, p=0.95) and was funded by the IP holder ^{2Reference 2Lopresti et al. · 2025RCTThe effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults — [RCT, branded; null on Raven’s fluid-intelligence and objective sleep]View study →}. A third trial (Zhang 2022, n=109 healthy Chinese adults) was positive on a memory battery but tested a combination formula (Magtein + phosphatidylserine + vitamins C and D), so the magnesium contribution can’t be isolated ^{4Reference 4Zhang et al. · 2022RCTA Magtein®, magnesium L-threonate-based formula improves brain cognitive functions in healthy Chinese adults — [RCT, confounded: formula also contained phosphatidylserine + vitamins C and D]View study →}. The rodent basis — elevating brain magnesium enhances learning and memory, and reverses synaptic loss in Alzheimer’s-model mice — is genuinely strong ^{7,8Reference 7Slutsky et al. · 2010AnimalEnhancement of learning and memory by elevating brain magnesium — [animal, rat]View study →Reference 8Li et al. · 2013AnimalElevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in an Alzheimer’s disease mouse model — [animal, mouse]View study →}, and L-threonate itself modulates intraneuronal magnesium and synapse density in vitro ^{9Reference 9Sun et al. · 2016In vitroRegulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration — [in vitro / mechanism]View study →}, but this has not translated into robust, independent human confirmation. Gap: every positive human result is on a soft or self-referential endpoint from an industry-linked trial; the one hard, pre-specified cognitive test was null.

Sleep. Two RCTs support a sleep benefit. Hausenblas 2024 (n=80, 1 g/day, 21 days) improved subjective questionnaires and several Oura-ring metrics (deep/REM) ^{3Reference 3Hausenblas et al. · 2024RCTMagnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems — [RCT, industry-linked] (corrigendum 2025, PMID 40567408)View study →}; Lopresti 2025 improved subjective sleep-impairment and lowered resting heart rate / raised HRV, but showed no group difference on the objective wearable sleep measures and no change on most sleep subscales ^{2Reference 2Lopresti et al. · 2025RCTThe effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults — [RCT, branded; null on Raven’s fluid-intelligence and objective sleep]View study →}. Gap: short trials, small n, author/industry ties, and a subjective-beats-objective pattern that is the signature of expectancy effects.

Pain / opioid-sparing. Results are contradictory. In advanced-cancer patients, oral L-TAMS (1.5–2 g) slowed opioid dose escalation and eased opioid-induced constipation (Wu 2023, n=83) ^{5Reference 5Wu et al. · 2023RCTOral application of magnesium-L-threonate enhances analgesia and reduces the dosage of opioids needed in advanced cancer patients — [RCT]View study →}. But a post-mastectomy-pain trial (Ni 2023, n=109, 12 weeks) was flatly null — no reduction in persistent pain, mood, sleep, or cognition versus placebo ^{6Reference 6Ni et al. · 2023RCTA randomized, double-blind, placebo-controlled trial of magnesium-L-threonate for persistent pain after breast cancer surgery — [RCT, null]View study →}. Gap: one positive and one null trial in different pain contexts; no basis to recommend it for pain.

For magnesium’s well-evidenced general roles (deficiency correction, blood pressure, migraine, etc.), see the Magnesium hub — those apply to any adequately dosed form and are not specific to L-threonate.

Absorption & Tolerability

L-threonate is a low-elemental magnesium salt: by formula weight (Mg(C₄H₇O₅)₂, ~294.5 g/mol) it is only ~8% elemental magnesium, so a studied 2 g dose of compound delivers roughly 145–165 mg of actual magnesium — less than a single tablet of most other magnesium supplements, and at a much higher cost per milligram of magnesium. Its selling point is not whole-body magnesium status but preferential brain delivery: in rats, threonate-bound magnesium raised cerebrospinal-fluid magnesium more than other salts ^{7Reference 7Slutsky et al. · 2010AnimalEnhancement of learning and memory by elevating brain magnesium — [animal, rat]View study →}. That brain-delivery advantage has not been demonstrated in humans (no CSF/brain-magnesium data exist), so it remains a mechanistic hypothesis. On tolerability it performs well — the short trials report no significant adverse effects, and because it carries so little elemental magnesium it is less likely than high-dose oxide or citrate to cause the osmotic diarrhoea typical of magnesium salts.

Dosage

Trials used 1,000–2,000 mg of the compound per day (≈82–165 mg elemental magnesium — roughly 82 mg at the 1 g/day floor, 124 mg at 1.5 g, 165 mg at 2 g), usually split into two or three doses, for 3 to 12 weeks. These are doses studied in research, not a personal recommendation. If the goal is to correct or maintain magnesium status rather than to test the cognition hypothesis, a cheaper, higher-elemental form (glycinate, citrate) delivers far more magnesium per dose — see Magnesium for intake references (RDA/AI and the Tolerable Upper Intake Level, which counts elemental magnesium from any supplemental form).

Safety

Well tolerated in short RCTs (≤12 weeks), with no significant adverse events reported ^{1,2,3,5,6Reference 1Liu et al. · 2016RCTEfficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults — [RCT, small, industry-funded]View study →Reference 2Lopresti et al. · 2025RCTThe effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults — [RCT, branded; null on Raven’s fluid-intelligence and objective sleep]View study →Reference 3Hausenblas et al. · 2024RCTMagnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems — [RCT, industry-linked] (corrigendum 2025, PMID 40567408)View study →Reference 5Wu et al. · 2023RCTOral application of magnesium-L-threonate enhances analgesia and reduces the dosage of opioids needed in advanced cancer patients — [RCT]View study →Reference 6Ni et al. · 2023RCTA randomized, double-blind, placebo-controlled trial of magnesium-L-threonate for persistent pain after breast cancer surgery — [RCT, null]View study →}. Because the elemental magnesium load is small, gastrointestinal upset is less common than with high-dose inorganic salts, but the general magnesium cautions still apply: avoid unsupervised use in renal impairment (impaired clearance can allow magnesium to accumulate), and separate dosing from tetracycline and fluoroquinolone antibiotics, bisphosphonates, and levothyroxine by ≥2 hours, as magnesium binds and reduces their absorption. Long-term safety at these doses is not characterised — trials run weeks, not years.

Pregnancy & lactation

Verdict: not established — avoid this form for cognitive purposes in pregnancy/lactation. No pregnancy-specific data exist for magnesium L-threonate. Dietary/RDA-level magnesium is essential and safe in pregnancy, but that is an argument for magnesium generally, not for supplementing this niche, low-yield form to chase an unproven brain benefit. Decisions here belong with a clinician who has the full clinical picture.

Scope of this safety review (for honesty, not a claim):

• Interactions assessed? Yes — renal clearance; chelation with tetracyclines, fluoroquinolones, bisphosphonates, levothyroxine (shared with all magnesium forms).
• Pregnancy/lactation assessed? Not for this form — no MgT-specific data; general magnesium adequacy is covered on the hub.
• Upper Limit? Not for this form specifically. The IOM UL for supplemental magnesium (350 mg/day elemental, adults) is set on the hub and counts magnesium from any salt; a 2 g MgT dose (~145–165 mg elemental) sits below it.

References